Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1996 1
2000 1
2001 1
2002 4
2003 2
2004 4
2005 1
2010 3
2011 1
2012 1
2013 2
2014 3
2015 1
2016 2
2017 4
2018 7
2019 5
2020 4
2021 3
2022 3
2023 1
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

50 results

Results by year

Filters applied: . Clear all
Page 1
Changes in multiple sclerosis epidemiology in Finland over five decades.
Pirttisalo AL, Soilu-Hänninen M, Sumelahti ML, Krökki O, Murtonen A, Hänninen K, Sipilä JOT. Pirttisalo AL, et al. Among authors: sumelahti ml. Acta Neurol Scand. 2020 Sep;142(3):200-209. doi: 10.1111/ane.13295. Epub 2020 Jun 24. Acta Neurol Scand. 2020. PMID: 32500607 Free article. Review.
[Woman, hormones and migraine].
Sumelahti ML. Sumelahti ML. Duodecim. 2013;129(4):345-50. Duodecim. 2013. PMID: 23484351 Review. Finnish.
Real-world effectiveness of fremanezumab for the preventive treatment of migraine: Interim analysis of the pan-European, prospective, observational, phase 4 PEARL study.
Ashina M, Mitsikostas DD, Amin FM, Kokturk P, Schankin CJ, Sahin G, Pozo-Rosich P, Dorman PJ, Nežádal T, Poole AC, Martins IP, Sumelahti ML, Ramirez Campos V, Ahn AH, Lyras L, Tassorelli C. Ashina M, et al. Among authors: sumelahti ml. Cephalalgia. 2023 Nov;43(11):3331024231214987. doi: 10.1177/03331024231214987. Cephalalgia. 2023. PMID: 37987641 Free article. Clinical Trial.
Polygenic risk provides biological validity for the ICHD-3 criteria among Finnish migraine families.
Häppölä P, Gormley P, Nuottamo ME, Artto V, Sumelahti ML, Nissilä M, Keski-Säntti P, Ilmavirta M, Kaunisto MA, Hämäläinen EI, Ripatti S, Pirinen M, Wessman M, Palotie A, Kallela M; International Headache Genetics Consortium (IHGC). Häppölä P, et al. Among authors: sumelahti ml. Cephalalgia. 2022 Apr;42(4-5):345-356. doi: 10.1177/03331024211045651. Epub 2021 Oct 14. Cephalalgia. 2022. PMID: 34648375 Free PMC article.
Risk of cancer among Finnish multiple sclerosis patients.
Hongell K, Kurki S, Sumelahti ML, Soilu-Hänninen M. Hongell K, et al. Among authors: sumelahti ml. Mult Scler Relat Disord. 2019 Oct;35:221-227. doi: 10.1016/j.msard.2019.08.005. Epub 2019 Aug 5. Mult Scler Relat Disord. 2019. PMID: 31404761
50 results